Top Hedge Fund News, Member Posts, Hedge Fund Daily Indices and more!

2yrs ago Hedge Fund hedgeweek Views: 314

Alderwood Capital appoints two independent chairs

Submitted 27/07/2021 - 1:06pm

Alderwood Capital (Alderwood), a London-based fund manager, has appointed two Independent Chairs. Olive Darragh will chair the Partnership Committee of Alderwood Partners, the investment management side of the business, while Neil Cochrane will serve as Chairman of the Board of the Alderwood Fund as well as Chairman of the Valuations Committee.

The Partnership Committee is also comprised of external member representatives, including Victory Capital, and members of Alderwood’s Management team. It oversees and directs both the strategic direction and the management of the business.
 
The Fund Board is wholly independent of the investment manager, with a mandate to ensure that decisions taken by the investment manager are in the best interests of the the Fund’s investors.
 
Darragh's career has spanned more than 25 years as a senior executive and advisor in the investment management arena. She is currently the CEO of Darragh Inc, a consulting firm, and CEO and Founder of Zolio, a platform developed to attract and train new entrants in the investment industry.She was previously a Partner at leading global hedge fund, Tudor Investments, where she served on the Operating Committee, chaired the firm’s Strategy Committee and sat on multiple advisory boards representing Tudor’s external investments. Prior to her roles at Tudor, Darragh was a Senior Partner at McKinsey & Company where she co-founded and led the firm’s global Investment Management practice for many years as well as serving on McKinsey’s global Partner Election and Review Committee. Since 2019 she has served as an Independent Board Member for Columbia Threadneedle Funds, the USD500 billion international asset manager.
 
Cochrane is currently the Chairman of Aware Super - an Australian Industry Superannuation fund with AUD145 billion under management on behalf of 1.1 million members. He is a member of the Investment Committee and chairs the Governance and Nominations Committee. In a career spanning 42 years in financial services, Neil’s previous roles have included Deputy CEO and Global Head of Business Development at Colonial First State Global Asset Management (CFSGAM); CEO of the Retail Employees Superannuation Trust (REST Industry Super) and CEO of Southern Asset Management in South Africa.
 
Cochrane and Darragh will formally take up their positions in July 2021.

Jon Little, Managing Partner of Alderwood Capital, says: “These are important appointments for Alderwood, and underline our commitment to ensure best in class governance at all levels of the Alderwood business. Institutional investors today quite rightly expect high standards of scrutiny and transparency – especially in respect of private assets. Both Neil and Olive bring a wealth of experience and their guidance will be a tremendous benefit to Alderwood as we seek to deploy our differentiated investment approach.  All of the management team here is looking forward to working with them.”

Like this article? Sign up to our free newsletter Related Topics Moves & Appointments

Today's Hedge Fund Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.